// App-Quantinova.ai

: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN OVERCOME THE POOR OUTCOME OF ADULT PH(+) ACUTE LYMPHOBLASTIC LEUKEMIA -- ON BEHALF OF TAIWAN SOCIETY OF BLOOD AND MARROW TRANSPLANTATION

Researchers

Presenter

  • Tran-Der Tan

Principal Investigators

  • Jih-Luh Tang

  • Ming Yao

  • Jyh-Pying Gau

  • Po-Nan Wang

  • Su-Peng Yeh

  • Tsai-Yun Chen

  • Chieh-Lin Teng

  • Yi-Chang Liu

Medical Centers

  • Department of Hematology and Medical Oncology,Koo Foundation Sun Yat-Sen Cancer Center,Taipei City,Taiwan, Province of China

  • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan

  • Department of Internal Medicine,Veteran General Hospital,Taipei,Taiwan, Province of China

  • Department of Internal Medicine,Veteran General Hospital,Taipei,Taiwan, Province of China

  • Department of Urology, China Medical University Hospital, Taichung, Taiwan

  • Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan

  • Department of Internal Medicine,Veteran General Hospital,Taipei,Taiwan, Province of China

  • Department of Internal Medicine, Division of Nephrology,Kaohsiung Medical University Hospital,Kaohsiung,Taiwan, Province of China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved